| Property | Value |
|---|
|
?:abstract
|
-
Immunotherapy is the newest approach to combat cancer It can be achieved using several strategies, among which is the dendritic cell (DC) vaccine therapy Several clinical trials are ongoing using DC vaccine therapy either as a sole agent or in combination with other interventions to tackle different types of cancer Immunotherapy can offer a potential treatment to coronavirus disease 2019 (COVID-19) the worst pandemic facing this generation, a disease with deleterious effects on the health and economic systems worldwide We hypothesize that DC vaccine therapy may provide a potential treatment strategy to help combat COVID-19 Cancer patients are at the top of the vulnerable population owing to their immune-compromised status In this review, we discuss DC vaccine therapy in the light of the body\'s immunity, cancer, and newly emerging infections such as COVID-19 in hopes of better-customized treatment options for patients with multiple comorbidities
|
|
is
?:annotates
of
|
|
|
?:creator
|
|
|
?:journal
|
|
|
?:license
|
|
|
?:publication_isRelatedTo_Disease
|
|
|
is
?:relation_isRelatedTo_publication
of
|
|
|
?:source
|
|
|
?:title
|
-
Dendritic cell vaccine immunotherapy;the beginning of the end of cancer and COVID-19. A hypothesis
|
|
?:type
|
|
|
?:who_covidence_id
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}